๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Tegileridine Combined With Intercostal Nerve Block After Thoracoscopic Lung Resection

RecruitingNAAges 18 Years - 75 YearsAllTongji Hospital
NCT07386626 on ClinicalTrials.gov โ†—
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Combining tegileridine PCIA with ICNB targeting peripheral nerves, may constitute an ideal analgesic model with complementary advantages. Thus potentially achieving the analgesic goal of "early pain relief, stable throughout the process, and rapid recovery," and may have a positive impact on reducing CPSP.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age range: 18 to 75 years old; * Patients undergoing elective thoracoscopic lobectomy or segmentectomy; * ASA classification levels I-III; * BMI 18 \~ 30 kg/m2ใ€‚ * Voluntarily participate and sign an informed consent form. Exclusion Criteria: * Patients with preoperative alcohol dependence and long-term use of analgesic drugs are receiving analgesic treatment for other acute and chronic pain; * Pregnant or lactating women; * Allergies or other contraindications to the anesthetics, analgesics, and antiemetic drugs used in the study; * Patients with severe sleep apnea syndrome or acute or severe bronchial asthma; * Suffering from mental and neurological disorders or cognitive impairment, known or suspected gastrointestinal obstruction, severe liver and kidney dysfunction (Child Pugh score C), chronic obstructive pulmonary disease or severe cardiovascular disease, etc; * Researchers consider participants who are not suitable to participate in this study and those who refuse to participate.
๐Ÿ’Š

What it tests

  • Tegileridine
  • Intercostal Nerve Block
  • Sufentanil
๐Ÿ“

Where

1 site
Tongji hospital
Wuhan, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy